Literature DB >> 11576735

Chromosomal abnormalities in oocytes.

M Plachot1.   

Abstract

Since the beginning of in vitro fertilization (IVF), basic research has provided insight in the field of human reproduction, especially in genetics. Indeed, the contribution of chromosomal abnormalities to oocyte disorders and impaired embryonic development is now well known. Of oocytes that fail to fertilize after in vitro insemination, 26.5% have been found to be abnormal, with 13.3% showing hypohaploidy, 8.1% hyperhaploidy, 1.6% structural abnormalities and 3.5% diploidy. The total incidence of abnormalities seems to be correlated with the fertility status of the woman. It is higher in oocytes from women with tubal or unexplained infertility than in those from women whose husband's infertility is the sole cause of infertility in the couple. Although few oocytes recovered during natural cycles have been studied, gonadotropins, which are widely used to stimulate follicle growth and ovulation, do not increase the risk of abnormalities. The effect of maternal age on fetal aneuploidy, well documented at birth, has not been unambiguously shown to result from an increase in the frequency of aneuploid oocytes. Intra- and extra-follicular influences (perifollicular microvasculature, oxygenation, and the presence of residues from cigarette smoke) may disturb maturation, leading to immaturity and aneuploidy. Thus, oocyte meiosis is very sensitive to endogenous and exogenous factors that could result in oocytes with chromosomal abnormalities and therefore, abnormal zygotes.

Entities:  

Mesh:

Year:  2001        PMID: 11576735     DOI: 10.1016/s0303-7207(01)00577-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells.

Authors:  Lauren M Zasadil; Eric M C Britigan; Beth A Weaver
Journal:  Semin Cell Dev Biol       Date:  2013-02-13       Impact factor: 7.727

2.  Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy.

Authors:  I Hammoud; F Vialard; M Bergere; M Albert; D Molina Gomes; M Adler; L Malagrida; M Bailly; R Wainer; J Selva
Journal:  J Assist Reprod Genet       Date:  2012-08-14       Impact factor: 3.412

3.  Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue.

Authors:  Dmitry Nikiforov; Cheng Junping; Jesus Cadenas; Vallari Shukla; Robert Blanshard; Susanne Elisabeth Pors; Stine Gry Kristensen; Kirsten Tryde Macklon; Lotte Colmorn; Erik Ernst; Anne-Mette Bay-Bjørn; Zeinab Ghezelayagh; Yu Wakimoto; Marie Louise Grøndahl; Eva Hoffmann; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

4.  Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome.

Authors:  Shweta Rajani; Ratna Chattopadhyay; Sourendra K Goswami; Sanghamitra Ghosh; Sunita Sharma; Baidyanath Chakravarty
Journal:  J Hum Reprod Sci       Date:  2012-05

5.  Impact of oocytes with CLCG on ICSI outcomes and their potential relation to pesticide exposure.

Authors:  Philippe Merviel; Rosalie Cabry; Karen Chardon; Elodie Haraux; Florence Scheffler; Naima-Belhadri Mansouri; Aviva Devaux; Hikmat Chahine; Véronique Bach; Henri Copin; Moncef Benkhalifa
Journal:  J Ovarian Res       Date:  2017-07-10       Impact factor: 4.234

6.  The effects of biological aging on global DNA methylation, histone modification, and epigenetic modifiers in the mouse germinal vesicle stage oocyte.

Authors:  Kira Lynn Marshall; Juanbin Wang; Tieming Ji; Rocío Melissa Rivera
Journal:  Anim Reprod       Date:  2018-12-05       Impact factor: 1.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.